S.A. Popov et al. / Journal of Molecular Structure 697 (2004) 49–60
59
4.12. 2-(2,4-Dimethylphenyl)-1-methoxy-4,4,5,5-
tetramethyl-4,5-dihydro-1H-imidazole 3Bg
3.76 (s, 3H, OCH3), 6.83 (dd, J3 ¼ 8.9 Hz, J4 ¼ 2.5 Hz, 20-
H, Ph), 7.46 (dd, J3 ¼ 8.9 Hz, J4 ¼ 2.5 Hz, 30-H, Ph). 13C
NMR (CDCl3, 50.3 MHz, d, ppm): 18.6 (CH3CO), 19.7,
23.9 (4,5-(CH3)2), 55.0 (OCH3), 68.0 (C-4), 72.2 (C-5),
113.5 (C30), 122.7 (C10), 128.9 (C20), 161.1 (C40), 163.5 (C-
2), 169.1 (CyO).
2-(2,4-Dimethylphenyl)-1-methoxy-4,4,5,5-tetramethyl-
4,5-dihydro-1H-imidazole 3Bg was synthesized similarly to
imidazoline 3Bb. Reaction time was 1 h at 100 8C (dioxane
1
1
as solvent); yield 69%. Oil. H NMR (CDCl3, 200.1 MHz,
2g. Yield 85%. H NMR (CDCl3, 200.1 MHz, d, ppm):
d, ppm): 1.19 (s, 6H), 1.22 (s, 6H, 4,5-(CH3)2), 2.30 (s, 3H),
2.34 (s, 3H, 2,4-(CH3)2-Ph), 3.43 (s, 3H, OCH3), 6.97 (d,
1H, J3 ¼ 7.6 Hz, 50-H, Ph) 6.99 (s, 1H, 30-H, Ph), 7.13 (d,
1H, J3 ¼ 7.6 Hz, 60-H, Ph). 13C NMR (CDCl3, 50.3 MHz, d,
ppm): 19.3, 23.2 (4,5-(CH3)2), 19.1, 21.0 (2,4-(C H3)2-Ph),
63.5 (OCH3), 67.4 (C-4), 71.0 ppm (C-5), 128.3 (C10),
125.4, 128.0, 130.4 (C30, C50, C60), 136.1, 138.2 (C20, C30),
165.4 (C-2). Found, m=z : 260.18885. Calculated for
C16H24N2O, m=z : 260.18886.
1.08 (s, 6H), 1.16(s, 6H, 4,5-(CH3)2), 1.70 (CH3CO), 2.15
(s, 3H, 40-CH3Ph), 2.23 (s, 3H, 20-CH3Ph), 6.81 (d, 1H,
J ¼ 7.8 Hz, 50-H, Ph), 6.86 (s, 1H, 30-H, Ph), 6.98 (d, 1H,
J3 ¼ 7.8 Hz, 60-H, Ph); 13C NMR (CDCl3, 50.3 MHz, d;
ppm): 18.8 (C H3CO), 19.2, 23.3 (4,5-(CH3)2), 20.7, 21.5
(4,5-(C H3)Ph), 68.0 (C-4), 71.6 (C-5), 126.6 (C10), 125.4,
127.6, 130.6 (C30, C50, C60), 136.3, 138.6 (C20, C40), 163.9
(C-2), 168.1 (CyO).
1
2k. Yield 90%. H NMR (CDCl3, 200.1 MHz, d, ppm):
1.12 (s, 6H), 1.21 (s, 6H, 4,5-(CH3)2), 2.16 (s, 3H, CH3CO),
6.37 (d, 1H, J3 ¼ 16.3 Hz, HCyCH–Ph), 7.46 (d, 1H,
J3 ¼ 16.3 Hz, HCyCH–Ph), 7.24–7.31 (m, 3H), 7.39–
7.4 ppm (m, 2H, Ph). 13C NMR (CDCl3, 50.32 MHz, d,
ppm): 18.5 (CH3CO), 19.1, 20.5 (4,5-(CH3)2), 67.5 (C-4),
72.1 (C-5), 114.8 (C10), 127.0, 128.3 (C40, C50), 128.8 (C60),
135.2 (C30), 138.0 (C20), 161.1 (C-2), 168.8 (CyO).
4.13. 1-(Acetyloxy)-2,4,4,5,5-pentamethyl-4,5-dihydro-1H-
imidazole 2c
Acetic anhydride (0.47 ml, 4.99 mmol) was added
dropwise with stirring to a solution of 1c (0.26 g,
1.66 mmol) in anhydrous chloroform (5 ml). The stirring
was continued for 30 min; the solution was washed with an
aqueous solution of KHCO3, water, and then dried with
MgSO4. After solvent removal, 2c (0.311 g, 94%) was
4.15. 1-(Acetyloxy)-2-mesityl-4,4,5,5-tetramethyl-4,5-
dihydro-1H-imidazole 2h
1
obtained. H NMR (CDCl3, 200.1 MHz, d, ppm): 1.03 (s,
6H), 1.09 (s, 6H, 4,5-(CH3)2), 1.83 (s, 3H, 2-CH3), 2.09 (s,
3H, CH3–CO). 13C NMR (CDCl3, 50.3 MHz, d, ppm): 13.6
(2-CH3), 18.2 (CH3–CO), 18.9, 23.1 (4,5-(CH3)2), 66.9 (C-
4), 71.7 (C-5), 162.8 (C-2), 168.4 (CyO). n; cm21: 1796
(CyO), 1652 (CyN).
A solution of acetic anhydride (0.075 ml, 0.74 mmol)
and triethylamine (0.20 ml, 1.35 mmol) in anhydrous
chloroform (2 ml) was added dropwise with stirring to a
solution of 1h (0.080 g, 0.31 mmol) in anhydrous chloro-
form (3 ml). The stirring was continued for 1 h at 20 8C, the
solvent was removed, and the residue dissolved in
anhydrous ether (10 ml). The triethylammonium acetate
precipitate was filtered off and the filtrate evaporated.
Imidazoline 2h was purified by chromatography on alumina
4.14. 2-R-1-(Acetyloxy)-4,4,5,5-tetramethyl-4,5-dihydro-
1H-imidazoles 2d,e,f,g,k
1
2-R-1-(Acetyloxy)-4,4,5,5-tetramethyl-4,5-dihydro-1H-
imidazoles 2d,e,f,g,k were obtained similarly.
with chloroform as eluent. Yield 0.050 g (54%). H NMR
(CDCl3, 200.1 MHz, d, ppm): 1.22 (s, 6H), 1.28 (s, 6H, 4,5-
(CH3)2), 1.76 (s, 3H, CH3CO), 2.21 (s, 3H, 40-CH3Ph, 2.24
(s, 6H, 20,60-(CH3)2Ph), 6.75 (s, 3H). 13C NMR (CDCl3,
50.3 MHz, d, ppm): 18.2 (CH3CO), 19.2, 23.8 (4,5-(CH3)2),
20.3, 20.9 (20,40,60-(CH3)3Ph), 68.7 (C-4), 71.2 (C-5), 126.7
(C10), 127.6 (C30), 136.6 (C20), 138.2 (C40), 163.5 (C-2),
168.2 (CyO).
1
2d. Yield 82%. H NMR (CDCl3, 200.1 MHz, d, ppm):
1.16 (s, 6H), 1.25 (s, 6H, 4,5-(CH3)2), 1.95 (s, 3H, CH3CO),
7.31–7.38 (m, 3H, Ph), 7.52 (dd, 2H, J3 ¼ 7.9 Hz,
J5 ¼ 1.7 Hz, 20-H, Ph. 13C NMR (CDCl3, 50.3 MHz, d,
ppm): 18.6 (C H3CO), 19.7, 23.9 (4,5-(CH3)2), 68.3 (C-4),
72.4 (C-5), 127.3, 128.1 (C20,C30), 130.1 (C40), 130.5 (C10),
164.0 (C-2), 168.9 (CyO). lmax; (ethanol), nm ðlog 1Þ :
229 nm (4.02). n; cm21: 3064 (Ar–H), 1779 (CyO), 1630
(CyN), 1602, 1578 (CyC).
4.16. 1,2,4,4,5,5-Hexamethyl-4,5-dihydro-1H-imidazole 3-
oxide 3Ac
1
2e. Yield 95%. H NMR (CDCl3, 200.1 MHz, d, ppm):
1.18 (s, 6H), 1.27 (s, 6H, 4,5-(CH3)2), 1.99 (s, 3H, CH3CO),
7.71 (dd, 2H J3 ¼ 9.0 Hz, J4 ¼ 2.1 Hz, 20-H, Ph), 8.20 (dd,
2H, J3 ¼ 9.0 Hz, J4 ¼ 2.1 Hz, 30-H, Ph). 13C NMR (CDCl3,
50.3 MHz, d, ppm): 18.6 (C H3CO), 19.7, 23.8 (4,5-(CH3)2),
69.4 (C-4), 73.0 (C-5), 123.4 (C30), 128.5 (C20), 136.7 (C10),
148.9 (C40), 162.5 (C-2), 168.8 (CyO);
A solution of 2c (0.311 g, 1.57 mmol) and dimethyl
sulphate (0.44 ml, 4.65 mmol) in anhydrous ether (9 ml)
was kept for 48 h at 10 8C. The precipitate was filtered off
and washed with anhydrous ether to give 0.411 g of 1-
(acetyloxy)-2,3,4,4,5,5-hexamethyl-4,5-dihydro-1H-imida-
zol-3-ium methylsulphate. The latter was dissolved in 5%
NaOH (5 ml) and the resulting solution was kept for 10 min
at 20 8C. The solution was extracted with chloroform
1
2f. Yield 90%. H NMR (CDCl3, 200.1 MHz, d, ppm):
1.14 (s, 6H), 1.22 (s, 6H, 4,5-(CH3)2), 1.97 (s, 3H, CH3CO),